Universal Ibogaine (TSXV:IBO) Other Income (Expense) : C$-1.00 Mil (TTM As of Jan. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Other Income (Expense)?

Universal Ibogaine's other income expense for the Universal Ibogaine's pretax income for the three months ended in Jan. 2025 was C$-0.01 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jan. 2025 was C$-1.00 Mil.

Universal Ibogaine Other Income (Expense) Historical Data

The historical data trend for Universal Ibogaine's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Other Income (Expense) Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Jul24

Other Income (Expense)

Get a 7-Day Free Trial

-0.06

-0.21

-5.68

-0.19

-0.99

Universal Ibogaine Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Other Income (Expense)	Get a 7-Day Free Trial															0.01	-0.39	-0.60	-	-0.01

Universal Ibogaine Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.00 Mil.

Universal Ibogaine (TSXV:IBO) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024